UC HEALTH LINE: Meds Not Always Best Solution for Chronic Heartburn
CincinnatiIf you constantly pop pills and still suffer from irritating heartburn, there may be an underlying problem more effectivelyand safelyaddressed with surgery.
"The choice to have surgery often comes down to a matter of convenience or cancer prevention, explains Thomas Husted, MD, a general surgeon with UC Health and clinical instructor at the University of Cincinnati College of Medicine.
According to Husted, many otherwise healthy young patients have an aversion to taking pills long-term to avoid reflux, so surgery to correct the underlying anatomical problem can be a more appealing solution. Other patients simply dont experience relief from acid reflux symptoms with medication, so surgical correction is the only way to stop the problem.
"This is especially important for people who have a low-grade Barretts esophagus, a precancerous condition that puts certain patients at higher risk for esophagus cancer, adds Husted. "When the problem is identified early, surgery can stop the tissue changes that lead to esophageal cancer.
Recent studies published in the Archives of Internal Medicine suggest the risks of taking proton pump inhibitor medications for acid reflux may outweigh the benefits for people with less serious conditions. According to the research, proton pump inhibitors can have rare but serious side effects, including bacterial infections and bone fractures.
Acid reflux, known medically as gastrointestinal reflux disease, occurs when there is a breakdown of the protective mechanism between the espophagus and the stomach.
"Several anatomic functions have to work together where the stomach and esophagus meet to avoid reflux. If a part of that protective system is flawed, the patient ends up with reflux and the patient often experiences chest pain and sour tastes in the mouth, explains Husted. "Proton pump inhibitors reduce the symptoms, but they do not stop the reflux or potential changes in the esophageal lining that can lead to cancer.
Patients who had anti-reflux surgeryknown medically as Nissen fundoplicationreport an 87 to 95 percent improvement in symptoms one year post-surgery without medication, according to data from the Society of American Gastrointestinal and Endoscopic Surgeons.
To perform the laparoscopic anti-reflux operation, the surgeon makes several small incisionshalf an inch or lessin the abdomen to insert thin surgical tools used during the procedure. Using video guidance from inside the abdomen, the surgeon then reinforces the valve between the esophagus and the stomach by wrapping the upper portion of the stomach around the lowest portion of the esophagus. Patients typically require a one-night hospital stay, but are able to return to regular activities within two weeks.
Husted is dually board-certified in general surgery and surgical critical care, with a specialization in laparoscopic gastrointestinal surgery. He sees patients at UC Healths Medical Office Building, located at 7700 University Court, Suite 2300, in West Chester. For appointment information, call (513) 475-7450. Husted performs surgical procedures at the West Chester Medical Center.
A full list of UC Health subspecialty and primary care physicians is available at ucphysicians.com.
Related Stories
UC expert weighs in on current MASH treatment approaches
June 5, 2026
As MedCentral recently reported, pending broader pharmacologic approvals for metabolic dysfunction-associated steatohepatitis (MASH), lifestyle modifications remain the go-to intervention.
At least two weather patterns increase headaches, UC study suggests
June 4, 2026
University of Cincinnati physicians and collaborators identified two specific weather patterns that increase headache and migraine risk and found the preventive medication fremanezumab (Ajovy) can reduce weather‑associated headaches. The findings will be presented at the American Headache Society Annual Scientific Meeting in Orlando.
UC researcher secures $3.3M grant to study microplastics’ impact on heart
June 2, 2026
The National Institute of Environmental Health Sciences awarded a $3.3M grant to University of Cincinnati researcher Hong‑Sheng Wang, PhD, to study how microplastics and nanoplastics affect cardiovascular health.